Axe Crew Cut
FDA Label NDC 64942-1161

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Conopco Inc. D/b/a Unilever for the product Axe Crew Cut (NDC 64942-1161). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - when using, otc - stop use, otc - keep out of reach of children, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredientsOctinoxate 7.0%, Oxybenzone 3.0%, Octisalate 1.0%

Otc - Purpose

PurposeSunscreen

Indications & Usage

Useshelps prevent sunburnhigher SPF gives more sunburn protectionprovides moderate protection from sunburn

Warnings

WarningsFor external use only.If swallowed, get medical help or contact a Poison Control Center right away.

Otc - When Using

When using this product keep out of eyes.  Rinse with water to remove.

Otc - Stop Use

Stop use and ask a doctor if rash or irritation develops.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Dosage & Administration

DirectionsRub onto head and scalp before sun exposure and as needed.  Children under 6 months of age: ask a doctor.

Inactive Ingredient

Inactive ingredientsWater, Glycerin, Beeswax, Cetearyl Alcohol, Glyceryl Stearate, VP/VA Copolymer, Sodium Behenoyl Lactylate, Fragrance, Carbomer, Triethanolamine, DMDM Hydantoin, Disodium EDTA, Iodopropynyl Butylcarbamate.

Otc - Questions

Questions?Visit us at www.TheAxeEffect.com or call us at 1-800-450-7580 Mon-Fri 8:30am - 6:00pm EST

Package Label.Principal Display Panel

Axe Buzzed Cut PDP front
Axe Buzz SPF15 back 1
Axe Buzz SPF15 back 2
Axe Buzz SPF15 back 3

* Please review the disclaimer below.